Dictyostelium Mutants

Phenotypes for Dictyostelium mutants

View other mutant types: All mutant strains - Null - Overexpression - Multiple - Other - Developmental

To view more details, including parent strains and references, click on the corresponding dictyBase ID.

Systematic Name	Strain Descriptor	Associated gene(s)	Phenotypes
DBS0351382	myoB-/ [act15]: GFP: myoB(1-921,1057-1111)	myoB	abolished protein localization to actin wave
DBS0266705	Dd5P1-/ Dd5P2-	Dd5P1 \| Dd5P2	increased chemotaxis to cAMP
DBS0266704	Dd5P1-/ Dd5P3-	Dd5P1 \| Dd5P3	increased chemotaxis to cAMP
DBS0266703	Dd5P2-/ Dd5P3-	Dd5P2 \| Dd5P3	wild type
DBS0351414	Dd5P4-/ [act15]: GFP: Dd5P4(D319G)	Dd5P4	increased contractile vacuole size \| aberrant contractile vacuole discharge \| aberrant protein localization to contractile vacuole
DBS0302615	GFP: phgA(1-274: 283-438)/ phgA-	phgA	aberrant hypotonic response
DBS0236084	GP138A-/ GP138B-/ GP138C-/ GP138D-	cfrA \| cfrB \| cfrC \| cfrD	decreased gene expression
DBS0351312	HSPC300-/ [act15]: abpB(129-295)	abpB \| hspc300	aberrant cellular process
DBS0236917	SA219	dscA-1 \| dscA-2 \| dscC-1 \| dscC-2 \| dscD-1 \| dscD-2 \| dscE	abolished gene expression
SA31	SA31	dscA-1 \| dscA-2 \| dscC-1 \| dscC-2 \| dscD-1 \| dscD-2 \| dscE	abolished gene expression \| abolished stream development \| aberrant microtubule cytoskeleton organization \| decreased establishment of cell polarity
DBS0350570	[AS]PARP	DDB_G0286613 \| DDB_G0289141 \| adprt1A \| adprt1B \| adprt2 \| adprt3 \| adprt4 \| pARTf \| pARTg	decreased cell death \| aberrant positive regulation of mitochondrial membrane potential
DBS0237228	[AS]cfrA/ [AS]cfrB	cfrA \| cfrB	decreased sexual fusion
DBS0351041	[AS]hspA/ [AS]ndkC-1	hspA \| ndkC-1 \| ndkC-2	wild type
DBS0350355	[AS]proA-/ proB-/ lmpA-	lmpA \| proA \| proB	abolished sporulation \| wild type
DBS0351311	[AS]proA/ abpB(129-295)	abpB \| proA	aberrant cellular process
DBS0236827	[AS]proA/ proB-	proA \| proB	decreased exocytosis \| decreased pinocytosis \| aberrant exocytosis \| increased actin filament polymerization \| development arrests at slug stage \| aberrant cytokinesis \| decreased cell motility \| abolished vegetative growth \| decreased secretion of lysosomal enzymes \| increased phagocytosis
DBS0238036	[AS]proA/ proB-/ [act15]: proA	proA \| proB	wild type
DBS0238037	[AS]proA/ proB-/ [act15]: proB	proA \| proB	wild type
DBS0238035	[AS]proA/ proB-/ [unk]: FLAG: proC	proA \| proB \| proC	wild type
DBS0350334	[AS]proA/ proB-/ scrA-	proA \| proB \| scrA	decreased exocytosis \| decreased pinocytosis \| decreased secretion of lysosomal enzymes
DBS0302685	[OE]: sgcA(1-2000)(N1106A): GFP/ gca-/ sgcA-	gcA \| sgcA	decreased chemotaxis rate
DBS0302683	[OE]: sgcA(878-2843)(N1106A): GFP/ gca-/ sgcA-	gcA \| sgcA	decreased chemotaxis rate
DBS0302681	[OE]: sgcA(878-2843): GFP/ sgcA-	gcA \| sgcA	aberrant chemotaxis to cAMP \| decreased chemotaxis rate
DBS0302682	[OE]: sgcA(N1106A): GFP/ gca-/ sgcA-	gcA \| sgcA	increased lateral pseudopodium formation \| aberrant chemotaxis to cAMP \| aberrant stream morphology \| decreased chemotaxis rate
DBS0302684	[OE]: sgcA: GFP/ gca-/ sgcA-	gcA \| sgcA	increased lateral pseudopodium formation \| decreased chemotaxis rate
DBS0350322	[act15]: FLAG: hbx4/ [act15]: cadA	cadA \| hbx4	wild type
DBS0350441	[act15]: GFP: talA/ mhcA-/ talA-	mhcA \| talA	aberrant protein localization
DBS0350986	[act15]: YFP: myoC(G395A)	myoC	decreased pinocytosis \| aberrant mitotic spindle organization \| decreased phagocytosis
DBS0351059	[act15]: gshB/ [AS]gpaB	gpaB \| gshB	aberrant stream morphology \| decreased establishment of cell polarity \| decreased sporulation
DBS0350397	[act15]: ifkA(881-1514(K1258G,F1320L))	ifkA	decreased growth rate \| increased protein level
DBS0350050	[act15]: myc: cdk8/ [act15]: FLAG: cycC	cdk8 \| cycC	precocious development of tipped mound
DBS0351051	[act15]: myc: talA(2255-2492)/ puf118(677-1036)	puf118 \| talA	aberrant chemotaxis to cAMP \| abolished protein localization to leading edge
DBS0351040	[act15]: snfA(1-379): GFP/ [AS]ndkC-1	ndkC-1 \| ndkC-2 \| snfA	wild type
DBS0350911	[act6]: GFP: cepA/ cepA(183-346)	cepA	increased number of centrosomes
DBS0351551	[act6]: GFP: lmnB(1-712)/ S122A	lmnB	aberrant intermediate filament bundle assembly
DBS0350498	[act6]: GFP: rab2A(N118I)	rab2A	aberrant cell-cell adhesion \| aberrant hypotonic response \| increased growth rate \| precocious development
DBS0350499	[act6]: GFP: rab2A(Q64L)	rab2A	decreased autophagic cell death \| aberrant cell-cell adhesion \| aberrant sorocarp development \| aberrant hypotonic response \| increased growth rate \| increased phagocytosis
DBS0350706	[cotC]: pkaC/ [spiA]: lacZ	pkaC \| spiA	precocious gene expression
DBS0350700	[ecmA]: pkaR(G135E/ G261A)/ [ecmB-frag]: lacZ	pkaR	abolished stalk cell differentiation
DBS0350196	[pkaC]: pkaC/ nsfA(A1854T,T1984A,C2131A,A2398T,T2574A)	nsfA \| pkaC	decreased spore cell differentiation
DBS0350696	[pkaC]: pkaC/ srfA-	pkaC \| srfA	aberrant spore coat morphology \| aberrant gene expression
DBS0351463	[tet]rasD(G12T)/ rigA-	rasD \| rigA	wild type
DBS0350494	[tgrB1]: [RNAi]abcB3/ [tgrC1]: GFP	abcB3	delayed development \| decreased cAMP level
DBS0350837	[unk]: rasD(G12T)/ [rasD]: rapA	rapA \| rasD	increased number of mound tips \| aberrant culmination \| decreased prespore cell differentiation \| aberrant gene expression \| decreased stalk cell differentiation
DBS0238439	[unk]: scrA(97-443): GFP	scrA	aberrant cytokinesis \| increased vegetative cell size \| decreased chemotaxis to cAMP \| aberrant cytoskeleton organization
DBS0350056	[unk]: tubA: GFP/ RNAi]cepG	cepG \| tubA	aberrant cytokinesis \| aberrant microtubule cytoskeleton organization \| aberrant protein localization to nuclear envelope \| aberrant centromere complex assembly
DBS0351237	[unk]: tubA: GFP/ [RNAi]cepL	cepL \| tubA	decreased growth rate \| aberrant cytokinesis \| aberrant microtubule cytoskeleton organization \| aberrant centromere complex assembly
DBS0236539	abcG2-/ abcG18-	abcG18 \| abcG2	decreased rate of endocytosis \| decreased growth rate \| abolished vegetative growth
DBS0236540	abcG2-/ abcG18-/ rtoA-	abcG18 \| abcG2 \| rtoA	decreased growth rate \| abolished vegetative growth
DBS0351535	abiA-/ pirA-/ AX2	abiA \| pirA	aberrant macropinocytosis \| decreased cell motility \| aberrant cell morphology
DBS0266689	abiA-/ scrA-	abiA \| scrA	decreased cell motility \| decreased vegetative cell size
DBS0235456	abpA-/ abpC-	abpA \| abpC	decreased pinocytosis \| decreased phagocytosis \| decreased growth rate \| decreased cell motility \| aberrant sorocarp development \| aberrant cell-cell adhesion \| aberrant hyperosmotic response
DBS0351087	abpB-/ abpA-	abpA \| abpB	decreased pinocytosis \| decreased growth rate \| increased cell-cell adhesion \| decreased vegetative cell size \| aberrant fruiting body morphogenesis \| aberrant hyperosmotic response \| precocious gene expression \| decreased chemotaxis to cAMP
DBS0351088	abpB-/ abpC-	abpB \| abpC	decreased prespore gene expression \| decreased prestalk gene expression \| aberrant fruiting body morphogenesis \| aberrant hyperosmotic response \| decreased chemotaxis to cAMP
DBS0235425	abpB-/ fimA-	abpB \| fimA	decreased vegetative cell size \| decreased fruiting body size \| decreased sporulation
DBS0350938	abpC-/ [act15]: abpC	abpC	wild type
DBS0351553	abpC-/ [act15]: qkgA(425-1553)	abpC \| qkgA-1 \| qkgA-2	aberrant actin filament polymerization
DBS0350720	acaA-/ [acaA-agg]: acaA: myc	acaA	decreased gene expression \| decreased fruiting body size
DBS0350721	acaA-/ [acaA-psp]: acaA: myc	acaA	decreased gene expression \| decreased mound size \| decreased fruiting body size
DBS0350722	acaA-/ [acaA-pst]: acaA: myc	acaA	wild type
DBS0350702	acaA-/ [act15]: HA: pkaC	acaA \| pkaC	wild type \| delayed development \| decreased cAMP level
DBS0350725	acaA-/ [act15]: HA: pkaC/ acrA-	acaA \| acrA \| pkaC	decreased gene expression \| abolished adenylate cyclase activity \| development arrests at tipped mound stage
DBS0350737	acaA-/ [act15]: acaA	acaA	aberrant slug development
DBS0350738	acaA-/ [act15]: acaA(1-390;398-1407)	acaA	abolished aggregation
DBS0350739	acaA-/ [act15]: acaA(L394T/ K482N)	acaA	wild type
DBS0350603	acaA-/ [act15]: cap: GFP	acaA \| cap	development arrests at loose mound stage \| increased calcium-dependent cell-cell adhesion \| wild type
DBS0350735	acaA-/ [act15]: pkaR(G135E/ G261A)	acaA \| pkaR	increased cAMP level
DBS0350736	acaA-/ [unk]: acaA(F306L/ S498G,K504E,E593V,I649T)	acaA	decreased gene expression \| abolished oscillatory cAMP signaling \| decreased cAMP level
DBS0350711	acaA-/ [unk]: acgA	acaA \| acgA	aberrant sorocarp development
DBS0306126	acapA-/ acapB-	acapA \| acapB	decreased sporulation
DBS0350194	acbA-/ [act15]: acbA(Y72A)	acbA	abolished spore cell differentiation
AK1211	acbA-/ tagA-	acbA \| tagA	increased prestalk B cell differentiation
DBS0350724	acrA-/ [pkaC]: pkaC	acrA \| pkaC	decreased spore germination \| decreased fruiting body size \| precocious development \| decreased sporulation
DBS0351190	adcC-/ [act15]: adcC(1-485)	adcC	decreased protein localization to plasma membrane
DBS0351189	adcC-/ [act15]: adcC(101-654): GFP	adcC	abolished protein localization to plasma membrane
DBS0350445	adcC-/ adcB-	adcB \| adcC	increased oscillatory cAMP signaling \| aberrant endocytosis \| delayed aggregation \| aberrant regulation of protein kinase activity
DBS0350541	adprt1A-/ adprt2-	adprt1A \| adprt2	decreased resistance to phleomycin \| decreased double-strand break repair via nonhomologous end joining \| decreased resistance to cisplatin
DBS0351603	agnA-/ agnB-	agnA \| agnB	aberrant production of siRNA involved in RNA interference \| increased gene expression
HW520	agtA-/ gnt1(1-253/ H104D)	agtA \| gnt1	development arrests at slug stage
DBS0349951	ampA-/ lmbd2B-	ampA \| lmbd2B	aberrant chemotaxis
DBS0349963	ampA-/ sma-	ampA \| sma	increased chemotaxis to folate \| increased cell-substrate adhesion
BS165	amtA-/ amtC-	amtA \| amtC	decreased protein localization to nucleus \| aberrant slug migration \| decreased ammonia level \| delayed gene expression
BS169	amtB-/ amtA-	amtA \| amtB	decreased ammonia level
BS168	amtB-/ amtC-	amtB \| amtC	decreased ammonia level
BS163	amtC-/ dhkC-	amtC \| dhkC	aberrant gene expression
DBS0236890	amtC-/ regA-	amtC \| regA	precocious sporulation
DBS0350299	aph1-/ ncstn-	aph1 \| ncstn	decreased phagocytosis \| decreased prespore cell differentiation
DBS0350300	aph1-/ psenA-	aph1 \| psenA	aberrant culmination \| abolished catalytic activity \| decreased prespore cell differentiation
DBS0350000	arpB+/ aprB-/ [act15]: myc: arpB(T235A/ T236A)	arpB	wild type
DBS0349998	arpB+/ aprB-/ [act15]: myc: arpB(Y200F/ T235A/ T236A)	arpB	decreased actin filament polymerization \| delayed aggregation \| decreased fruiting body size \| decreased establishment of cell polarity \| decreased chemotaxis to cAMP \| delayed gene expression
DBS0350206	arpin-/ [act15]: GFP: arpin	arpin	wild type
DBS0266655	atg1-/ iplA-	atg1 \| iplA	decreased necrotic cell death
DBS0252632	atg1-/ pcp-	atg1 \| pcp	abolished autophagosome organization
DBS0351613	atg1-/ tsg101-	atg1 \| tsg101	decreased defense response to Gram-positive bacterium
DBS0350838	atg1-/ vmp1-	atg1 \| vmp1	wild type \| abolished protein localization to autophagosome
DBS0351576	atg5-/ abpB-/ [dscB]: abpB(D93A/ D95A/ D97A): GFP	abpB \| atg5	aberrant cellular component organization \| abolished vegetative growth
DBS0351583	atg5-/ atg12-	atg12 \| atg5	increased cell death \| decreased catalytic activity \| decreased growth rate \| decreased phagocytosis \| increased protein modification \| decreased macropinocytosis \| aberrant fruiting body morphogenesis
DBS0351584	atg5-/ atg12-/ tipD-	atg12 \| atg5 \| tipD	increased cell death \| decreased catalytic activity \| decreased growth rate \| aberrant phagocytosis \| increased protein modification \| decreased macropinocytosis \| aberrant fruiting body morphogenesis \| increased growth rate
DBS0351477	atg7-/ [act15]: YFP: atg7(C563A)	atg7	aberrant sorus morphology \| decreased spore germination \| delayed development
DBS0351479	atg7-/ [act15]: pkaC: YFP	atg7 \| pkaC	decreased gene expression \| decreased sporulation
DBS0351224	atg8a-/ atg8b-	atg8a \| atg8b	increased cell death \| decreased catalytic activity \| decreased growth rate \| decreased phagocytosis \| increased protein modification \| aberrant sorocarp development \| aberrant lysosome organization
DBS0350535	atg9-/ [act15]: cdcD(R154C): RFP	atg9 \| cdcD	decreased growth rate \| decreased phototaxis
DBS0351589	atg9-/ [act15]: cdcD(R154C/ E219K): RFP	atg9 \| cdcD	wild type
DBS0350534	atg9-/ [act15]: cdcD: RFP	atg9 \| cdcD	decreased growth rate \| aberrant fruiting body morphogenesis \| abolished phototaxis
DBS0351480	atg9-/ [act15]: pkaC: YFP	atg9 \| pkaC	abolished sporulation
DBS0350731	atg9-/ tipD-	atg9 \| tipD	decreased pinocytosis \| aberrant phagosome maturation \| development arrests at tipped mound stage
DBS0351266	carA-/ [act15]: gpbA: YFP	carA-1 \| carA-2 \| gpbA	abolished aggregation
DBS0350431	carA-/ [unk]: carA(261-359;S299A,S302G,S303G,S304G,S308A,S324G,S325A,S331A)(369-392;S383A,S385A): eYFP	carA-1 \| carA-2	aberrant adaptation of signaling pathway \| aberrant protein localization to plasma membrane
RI9	carA-/ carC-	carA-1 \| carA-2 \| carC	decreased gene expression \| abolished protein localization to plasma membrane
RI4	carA-/ carC-	carA-1 \| carA-2 \| carC	decreased actin filament polymerization \| abolished activation of GTPase activity \| abolished aggregation \| abolished cGMP-mediated signaling \| abolished chemotaxis to cAMP
DBS0350568	carA-/ carC-/ [act15]: carA(261-359;S299A,S302G,S303G,S304G,S308A,S324G,S325A,S331A)(369-392;S383A,S385A)	carA-1 \| carA-2 \| carC	abolished stream development \| aberrant activation of adenylate cyclase activity \| aberrant chemotaxis to cAMP \| aberrant oscillatory cAMP signaling \| aberrant actin filament polymerization
DBS0235570	carB-	carB	development arrests at mound stage
DBS0350528	chdC-/ [ecmA]: lacZ	chdC	decreased prestalk cell differentiation
DBS0350527	chdC-/ [pspA]: lacZ	chdC	decreased prespore cell differentiation
DBS0351521	corA-/ [act15]: FLAG: corA(1-432)	corA	abolished aggregation
DBS0350851	corA-/ aip1-	aip1 \| corA	aberrant endocytosis \| aberrant cytokinesis \| increased actin filament polymerization \| development arrests at mound stage \| decreased growth rate \| aberrant nucleus morphology \| increased vegetative cell size \| increased protein level \| decreased chemotaxis to cAMP
DBS0351412	corA-/ mhcA-	corA \| mhcA	aberrant cytokinesis
DBS0351413	corA-/ piaA-	corA \| piaA	aberrant cytokinesis
TL53	cotA-/ cotB-	cotA \| cotB	aberrant spore coat morphology
TL56	cotA-/ cotB-/ cotC-	cotA \| cotB \| cotC	decreased spore germination \| aberrant spore coat morphology \| abolished cellulose binding
TL57	cotA-/ cotB-/ cotC-	cotA \| cotB \| cotC	aberrant spore coat morphology
TL54	cotB-/ cotC-	cotB \| cotC	aberrant spore coat morphology
HG1772	crtA-/ cnxA-	cnxA \| crtA	decreased calcium ion import \| decreased growth rate \| delayed response to cAMP \| decreased phagocytosis \| aberrant calcium-mediated signaling
TL73	csaA-/ csbA-/ csbC-/ csbC-	csaA \| csbA \| csbB \| csbC	increased stalk width \| aberrant late culminant morphology
TL122	csaA-/ tgrC1-	csaA \| tgrC1	abolished calcium-independent cell-cell adhesion
TL72	csbA-/ csbB-/ csbC-	csbA \| csbB \| csbC	increased resistance to cisplatin \| aberrant cytokinesis \| aberrant late culminant morphology
DBS0304928	ctnnA-/ mhcA-	ctnnA \| mhcA	aberrant cytokinesis
DBS0237568	ctxA-/ [RNAi]enlA	ctxA \| enlA	wild type
DBS0235599	ctxA-/ ctxB-	ctxA \| ctxB	abolished stream development \| aberrant cellular response to fluid shear stress \| abolished adenylate cyclase activity \| increased lateral pseudopodium formation \| aberrant cytokinesis \| development arrests at mound stage \| aberrant chemotaxis to cAMP \| decreased cell motility \| aberrant regulation of GTPase activity \| aberrant cell morphology \| abolished aggregation \| aberrant regulation of protein kinase activity \| increased bleb assembly
DBS0350293	ctxA-/ ctxB-/ [act15]: GFP: arcA	arcA \| ctxA \| ctxB	aberrant protein localization to cell cortex
DBS0349972	ctxA-/ ctxB-/ [act15]: acaA: YFP	acaA \| ctxA \| ctxB	aberrant fruiting body morphogenesis
DBS0349973	ctxA-/ ctxB-/ [act15]: carA: YFP	carA-1 \| carA-2 \| ctxA \| ctxB	abolished stream development \| abolished adenylate cyclase activity \| development arrests at tight mound stage
DBS0266760	culB-/ pkaR-	culB \| pkaR	abolished sporulation \| precocious prestalk gene expression \| abolished aggregation \| abolished prespore gene expression
DBS0349807	detA-/ [act6]: GFP: detA	detA	wild type
DBS0349816	detA-/ [act6]: GFP: detA/ [act6]: 3xHA: culD	culD \| detA	increased gene expression
DBS0349817	detA-/ [act6]: GFP: detA/ [act6]: 3xHA: repE	detA \| repE	increased gene expression
DBS0350393	dgat1-/ dgat2-	dgat1 \| dgat2	abolished lipid droplet formation \| decreased growth rate \| increased sporulation \| aberrant endoplasmic reticulum membrane organization
DBS0349917	dgcA-/ [act15]: dgcA(1-124): YFP	dgcA	development arrests at slug stage
DBS0349918	dgcA-/ [act15]: dgcA(1-273): YFP	dgcA	development arrests at slug stage
DBS0349916	dgcA-/ [act15]: dgcA(350-521): YFP	dgcA	development arrests at slug stage
DBS0350665	dhkA-/ [act15]: dhkA(D2076N)	dhkA	decreased sporulation
DBS0350664	dhkA-/ [act15]: dhkA(H1396Q)	dhkA	decreased sporulation
DBS0350666	dhkA-/ [act15]: dhkA(H2396Q)/ [act15]: dhkA(D2076N)	dhkA	wild type
TL134	dhkA-/ dhkB-	dhkA \| dhkB	abolished sporulation \| increased stalk length \| decreased stalk width
HR49	dhkA-/ fbxA-	dhkA \| fbxA	aberrant fruiting body morphogenesis \| decreased sporulation \| decreased cAMP level
HR51	dhkA-/ fbxA-	dhkA \| fbxA	aberrant fruiting body morphogenesis \| decreased sporulation
HR50	dhkA-/ fbxA-	dhkA \| fbxA	abolished culmination \| decreased sporulation
DBS0350663	dhkA-/ pkaR-	dhkA \| pkaR	decreased sporulation
DBS0350662	dhkA-/ regA-	dhkA \| regA	decreased sporulation
DBS0235714	dhkK-/ regA-	dhkK \| regA	precocious development
DBS0235899	dimA-/ dimB-	dimA \| dimB	increased migratory slug size \| increased standing slug length \| aberrant chemotaxis to cAMP \| decreased standing slug width
DBS0351395	dlpA-/ dlpB-	dlpA \| dlpB	aberrant cytokinesis
HM1196	dmtA-/ stlA-	dmtA \| stlB	decreased outer basal disc size \| decreased prestalk O cell differentiation
DBS0350561	dnapkcs-/ adprt2-	adprt2 \| dnapkcs	decreased resistance to phleomycin \| decreased resistance to cisplatin
DBS0351060	dnapkcs-/ exo1-	dnapkcs \| exo1	decreased resistance to phleomycin
DBS0350459	docD-/ docA-	docA \| docD	aberrant fruiting body morphogenesis \| delayed development \| decreased chemotaxis to cAMP
HAD205	dpoA-/ gskA-	dpoA \| gskA	aberrant sorocarp development
DBS0302608	dsgg(1-571: 581-733)/ dsgg-	dsgg	aberrant contractile vacuole organization \| aberrant cellular localization
DBS0302606	dsgg-/ [OE]: GFP: lvsD	dsgg \| lvsD	wild type
DBS0302607	dsgg-/ [OE]: lvsA	dsgg \| lvsA	aberrant contractile vacuole organization
DBS0302611	dsgg-/ [OE]: phgA	dsgg \| phgA	aberrant contractile vacuole organization
DBS0302604	dsgg-/ lvsA-	dsgg \| lvsA	wild type
DBS0302605	dsgg-/ lvsD-	dsgg \| lvsD	aberrant contractile vacuole organization
DBS0235927	dstA-/ dstB-	dstA \| dstB	wild type
DBS0235932	dstB-/ dstC-	dstB \| dstC	wild type
DBS0350414	dydA-/ dydA(1-278: 501-1211)	dydA	decreased protein localization to cell cortex \| increased myosin II assembly \| increased actin filament polymerization \| aberrant chemotaxis to cAMP
DBS0350415	dydA-/ dydA(1-586: 703-1211)	dydA	decreased protein localization to cell cortex \| decreased chemotaxis to cAMP
DBS0350803	dymA-/ ehd-	dymA \| ehd	aberrant phagosome maturation \| decreased protein processing in phagocytic vesicle
DBS0350521	egeA-/ [unk]: pkaC	egeA \| pkaC	decreased gene expression \| abolished aggregation
DBS0350804	ehd-/ [act15]: dymA: GFP	dymA \| ehd	aberrant phagosome maturation \| decreased protein processing in phagocytic vesicle
DBS0302598	elmoA-/ [act15]: elmoA(1-903/ 959-977): GFP	elmoA	decreased cell motility \| increased phagocytosis
DBS0302474	epnA-/ [act15]: epnA(R65A/ K78A): GFP	epnA	aberrant spore morphology \| abolished protein localization to plasma membrane \| abolished phosphatidylinositol-4,5-bisphosphate binding \| abolished protein localization to clathrin-coated pit \| abolished protein phosphorylation
DBS0302475	epnA-/ [act15]: epnA(T107A): GFP	epnA	aberrant spore morphology \| abolished protein localization to plasma membrane
DBS0350681	erkA-/ [act15]: gpaE	erkA \| gpaE	wild type
DBS0350029	erkA-/ [act15]: mekA: FLAG	erkA \| mekA	increased protein localization to cell cortex
DBS0351474	erkA-/ regA-	erkA \| regA	decreased mound size \| aberrant fruiting body morphogenesis
DBS0350682	erkB-/ [unk]: erkB(P140S)	erkB	abolished sporulation
DBS0235949	erkB-/ regA-	erkB \| regA	increased oscillatory cAMP signaling \| abolished aggregation
HR46	fbxA-/ regA-	fbxA \| regA	aberrant fruiting body morphogenesis \| decreased sporulation
HR48	fbxA-/ regA-	fbxA \| regA	aberrant fruiting body morphogenesis \| decreased sporulation
DBS0350129	fcsB-/ fcsA-	fcsA \| fcsB	decreased catalytic activity \| decreased growth rate \| delayed development
DBS0350955	fhbA-/ fhbB-	fhbA \| fhbB	aberrant cellular response to stress
HM1351	fncD2-/ rev3-	fncD2 \| rev3	decreased resistance to cisplatin
HM1405	fncD2-/ xpf-	fncD2 \| xpf	decreased resistance to cisplatin
DBS0235967	forA-/ forB-	forA \| forB	wild type
DBS0351307	forE-/ forA-/ forH-	forA \| forE \| forH	aberrant cortical actin cytoskeleton organization \| aberrant cytokinesis \| aberrant sorocarp development \| decreased cell motility \| aberrant cell morphology
DBS0235978	fszA-/ fszB-	fszA \| fszB	aberrant mitochondrion morphology
DBS0350077	gadA-/ gadB-	gadA \| gadB	delayed aggregation
DBS0350403	gapA-/ iqgC-	gapA \| iqgC	decreased protein kinase activation \| decreased chemotaxis to cAMP
DBS0349868	gbpC-/ [act15]: gbpC(1-2331: 2470-2631): GFP	gbpC	aberrant stream morphology \| decreased chemotaxis to cAMP
DBS0235996	gbpC-/ gbpD-	gbpC \| gbpD	delayed aggregation \| decreased chemotaxis rate \| decreased establishment of cell polarity \| increased bleb assembly
DBS0236000	gca-/ sgcA-	gcA \| sgcA	decreased protein kinase activation
DBS0302679	gca-/ sgcA-	gcA \| sgcA	increased lateral pseudopodium formation \| aberrant activation of GTPase activity \| aberrant chemotaxis to cAMP \| aberrant taxis \| aberrant stream morphology \| decreased mound size \| decreased chemotaxis rate \| decreased fruiting body size
DBS0236095	gdt1-/ gpaB-	gdt1 \| gpaB	increased gene expression \| abolished aggregation
DBS0236010	gefB-/ rasS-	gefB \| rasS	decreased phagocytosis \| increased cell motility
DBS0351462	gefE-/ uduB-	gefE \| uduB	wild type
DBS0350823	gefH-/ gefA-	gefA \| gefH	decreased actin filament polymerization \| aberrant chemotaxis to cAMP \| abolished activation of GTPase activity \| decreased protein kinase activation \| abolished aggregation
DBS0350814	gflB-/ [act15]: GFP: gflB(380-1601,T1180E)	gflB	decreased chemotaxis to cAMP
DBS0238605	gpaA-/ rpkA-	gpaA \| rpkA	delayed aggregation \| abolished aggregation
DBS0351103	gpaB-/ [act15]: gpaB(C4A)	gpaB	abolished protein localization to plasma membrane \| decreased cGMP-mediated signaling \| abolished aggregation
DBS0351105	gpaB-/ [act15]: gpaB(G207A)	gpaB	abolished protein localization to plasma membrane
DBS0351104	gpaB-/ [act15]: gpaB(G2A)	gpaB	abolished protein localization to plasma membrane
DBS0351217	gpaB-/ [act15]: gpaI	gpaB \| gpaI	wild type
DBS0351267	gpaB-/ [act15]: gpbA: YFP	gpaB \| gpbA	abolished aggregation
DBS0351214	gpaB-/ [act15]: rasG(S17N)	gpaB \| rasG	abolished activation of GTPase activity
DBS0350373	gpaB-/ regA-	gpaB \| regA	decreased number of mounds
DBS0350608	gpaD-/ [act15]: gpaD(Q200L)	gpaD	development arrests at loose mound stage \| decreased chemotaxis to folate \| decreased protein kinase activation
DBS0350607	gpaD-/ [act15]: gpaD(R107E,R108E)	gpaD	development arrests at slug stage \| aberrant slug development
DBS0351269	gpaD-/ [act6]: AEQ	gpaD	aberrant calcium-mediated signaling
DBS0350374	gpaD-/ regA-	gpaD \| regA	aberrant aggregation \| abolished slug migration \| decreased sporulation
DBS0350378	gpaD-/ regA-/ [ecmB]: lacZ	gpaD \| regA	increased prestalk O cell differentiation
DBS0350678	gpaE-/ [act15]: gpaE(K10E/ K11E)	gpaE	delayed development of tipped mound \| delayed gene expression
DBS0350624	gpaE-/ erkA-	erkA \| gpaE	wild type \| decreased mound size \| precocious development
LW17	gpbA-/ [act15]: carC	carC \| gpbA	abolished aggregation
DBS0351260	gpbA-/ [act15]: gpbA(A99T/ Y271H/ C335M)	gpbA	abolished activation of adenylate cyclase activity \| aberrant fruiting body morphogenesis
DBS0351261	gpbA-/ [act15]: gpbA(M30V/ K85R/ S104P/ Q163H)	gpbA	development arrests at mound stage \| abolished activation of adenylate cyclase activity \| decreased chemotaxis to cAMP
DBS0351263	gpbA-/ [act15]: gpbA(M48T/ I52T/ E310G)	gpbA	wild type \| decreased activation of adenylate cyclase activity \| decreased gene expression \| aberrant slug development
DBS0351259	gpbA-/ [act15]: gpbA(N147D/ H149R/ N237S)	gpbA	development arrests at mound stage \| abolished activation of adenylate cyclase activity \| abolished chemotaxis to cAMP
DBS0351264	gpbA-/ [act15]: gpbA(R13G/ N74S/ S79P/ H149R/ V178A/ V194R/ F293L)	gpbA	decreased activation of adenylate cyclase activity \| decreased gene expression \| development arrests at tipped mound stage
DBS0351262	gpbA-/ [act15]: gpbA(S196G/ V199D/ C211R)	gpbA	decreased activation of adenylate cyclase activity \| aberrant fruiting body morphogenesis
DBS0351258	gpbA-/ [act15]: gpbA(V88A/ F229S/ D235V)	gpbA	abolished activation of adenylate cyclase activity \| aberrant fruiting body morphogenesis \| decreased chemotaxis to cAMP
DBS0351268	gpbA-/ [act6]: AEQ	gpbA	aberrant calcium-mediated signaling
HO547	gpbA-/ [act6]: FRB: [act15]: RFP: gpbA/ [act15]: cnxA: CFP: FKBP/ [act15]: limE(1-145): GFP	gpbA	aberrant cortical actin cytoskeleton organization
DBS0351198	gpbA-/ [act6]: yakA	gpbA \| yakA	abolished vegetative growth
DBS0350078	grlB-/ grlE-	grlB \| grlE	decreased small molecule binding \| delayed aggregation
DBS0350284	grlJ-/ [act15]: grlJ: GFP	grlJ	wild type
DBS0349881	gskA-/ [act15]: gskA(Y214F)	gskA	abolished stream development
DBS0350260	gskA-/ [unk]: pikA(1-492(S7D/ S11D/ S109D/ S113D/ S177D/ S181D))	gskA \| pikA	wild type
DBS0351102	gskA-/ glkA-	glkA \| gskA	aberrant sorocarp development \| decreased chemotaxis to cAMP \| increased protein kinase activation
DBS0350269	gxcT-/ [act15]: GFP: gxcT	gxcT	wild type
DBS0350656	hatA-/ [hatB]: hatB	hatA \| hatB	aberrant cellular response to stress
DBS0236131	hbx2-/ warA-	hbx2 \| warA	increased basal disc size \| development arrests at mound stage \| decreased prespore cell differentiation \| increased prestalk O cell differentiation
DBS0350880	hbx9-/ [ecmA]: lacZ	hbx9	increased prestalk A cell differentiation
DBS0350364	hfnA-/ abpC-	abpC \| hfnA	wild type \| aberrant prestalk O cell differentiation \| decreased phototaxis
DBS0305951	hipA-/ epnA-	epnA \| hipA	decreased spore germination \| aberrant spore morphology
BS161	ifkA-/ ifkB-	ifkA \| ifkB	increased mound size \| increased number of mound tips \| increased cell-cell adhesion \| increased cell-substrate adhesion \| aberrant fruiting body morphogenesis
DBS0351436	ireA-/ [act15]: ireA(K603N): GFP	ireA	decreased protein level \| aberrant endoplasmic reticulum organization \| aberrant cellular response to stress
DBS0351437	ireA-/ [act15]: ireA(N927A): GFP	ireA	decreased protein level \| aberrant endoplasmic reticulum organization \| aberrant cellular response to stress
DBS0350959	kif10-/ [act15]: dhcA(1384-4725)	dhcA \| kif10	wild type
DBS0350042	kif4-/ [act15]: dhcA(1384-4725)	dhcA \| kif4	aberrant mitotic spindle organization
DBS0350947	kif8-/ [act15]: dhcA(1384-4725)	dhcA \| kif8	wild type
DBS0351457	kil1-/ lrrkA-	drkD \| kil1	aberrant defense response to bacterium
DBS0350044	kil2-/ [act15]: kil1	kil1 \| kil2	abolished defense response to bacterium
DBS0351458	kil2-/ lrrkA-	drkD \| kil2	aberrant defense response to bacterium
DBS0350875	kil2-/ vps13F-	kil2 \| vps13F	aberrant defense response to bacterium \| decreased growth rate
DBS0350600	krsB-/ krsA-	krsA \| krsB	aberrant stream morphology \| delayed development
DBS0350536	ku80-/ dclre1-	dclre1 \| ku80	wild type
DBS0236729	limB-/ paxB-	limB \| paxB	development arrests at mound stage
DBS0350565	limD1-/ limC-	limC \| limD1	delayed aggregation \| aberrant cytokinesis \| abolished vegetative growth \| aberrant response to osmotic stress \| decreased chemotaxis to cAMP \| aberrant actin filament organization \| decreased establishment of cell polarity
DBS0350453	lpten-/ [act15]: lpten: RFP	lpten	wild type
DBS0350114	lst8-/ [act15]: GFP: rheb(Q64L)	lst8 \| rheb	increased phagocytosis
DBS0350030	mekA-/ [act15]: Myc: erkA	erkA \| mekA	abolished protein localization to cell cortex
DBS0238098	mekA-/ ppp4C-	mekA \| ppp4c	decreased mound size
DBS0238109	mekA-/ ppp4C-/ [act15]: FLAG: pppC	ppp4c	decreased mound size \| precocious development
DBS0236542	mekA-/ smkA-	mekA \| smkA	decreased mound size
DBS0237564	mhcA-/ [act15]: GFP: ctxA/ [RNAi]enlA	ctxA \| enlA \| mhcA	aberrant mitotic actomyosin contractile ring contraction
DBS0350489	mhcA-/ [act15]: GFP: mhcA/ [RNAi]rmd1	mhcA \| rmd1	abolished protein localization to cleavage furrow
DBS0350808	mhcA-/ [act15]: mhcA(1-933: 1455-2116]	mhcA	wild type \| aberrant cytokinesis \| aberrant fruiting body morphogenesis
DBS0350668	mhcA-/ forA-	forA \| mhcA	abolished cell motility \| decreased cell motility
DBS0351411	mhcA-/ piaA-	mhcA \| piaA	aberrant cytokinesis
CW0431	mhkA-/ mhkB-/ mhkC-	mhkA \| mhkB \| mhkC	increased myosin II assembly \| decreased growth rate \| aberrant cytokinesis \| aberrant chemotaxis \| decreased cell motility
DBS0236556	mhkA-/ mhkC-	mhkA \| mhkC	increased myosin II assembly \| decreased growth rate \| aberrant cytokinesis
CW0394	mhkA/ mhkB	mhkA \| mhkB	increased myosin II assembly \| decreased growth rate \| aberrant cytokinesis
DBS0350123	midA-/ [act15]: GFP: atg18	atg18 \| midA	increased number of autophagosomes
DBS0350136	midA-/ [act15]: GFP: tkt	midA \| tkt-1 \| tkt-2	increased autophagy
DBS0351180	midA/ [act15]: midA(E200A)	midA	aberrant cellular homeostasis \| decreased growth rate \| decreased phototaxis
DBS0351182	midA/ [act15]: midA(G170V/ G172V)	midA	aberrant cellular homeostasis \| decreased growth rate \| decreased phototaxis
DBS0351181	midA/ [act15]: midA(N205A)	midA	aberrant cellular homeostasis \| decreased growth rate \| decreased phototaxis
DBS0350027	mip1-/ [act15]: mekA: FLAG	mekA \| mip1-1 \| mip1-2	aberrant protein localization to cytoplasm
DBS0309109	mipp1-/ dpoA-	dpoA \| mipp1	aberrant inositol phosphate metabolic process \| increased response to lithium
DBS0236561	mkcA-/ tagB-	mkcA \| tagB	decreased sporulation
DBS0236562	mkcA-/ tagC-	mkcA \| tagC	decreased sporulation
DBS0351550	mlcR-/ [ecmAO]: GFP	mlcR	aberrant development of tipped mound
DBS0349988	mrfA-/ dimB-/ [emcA]: lacZ	dimB \| mrfA	decreased prestalk A cell differentiation
DBS0304881	mrps4-	mrps4	delayed aggregation
DBS0351541	mscS-/ mclN-/ pkd2-	mcln \| mscS \| pkd2	aberrant calcium-mediated signaling
DBS0304882	mtDNA-	DidioMp05 \| DidioMp21 \| DidioMp26 \| DidioMp27 \| DidioMp30 \| DidioMp35 \| DidioMp36 \| ai2a \| ai2b \| ai3 \| ai4 \| atp1 \| atp4 \| atp6 \| atp8 \| atp9 \| cox1/ 2 \| cox3 \| cytB \| mrpl11 \| mrpl14 \| mrpl16 \| mrpl2 \| mrpl6 \| mrps12 \| mrps13 \| mrps14 \| mrps19 \| mrps2 \| mrps4 \| mrps7 \| mrps8 \| nad1 \| nad11 \| nad2 \| nad3 \| nad4 \| nad4L \| nad5 \| nad6 \| nad7 \| nad9 \| rnlA	abolished vegetative growth \| abolished aggregation
DBS0351489	mvpA-/ mvpB-	mvpA \| mvpB	decreased growth rate \| aberrant cellular component organization
HDT5	myoA-/ myoB-	myoA \| myoB	decreased pinocytosis \| increased secretion of lysosomal enzymes \| increased filopodium formation \| aberrant aggregation \| aberrant endosomal transport \| decreased defense response to Gram-negative bacterium \| aberrant cortical actin cytoskeleton organization \| increased lateral pseudopodium formation \| decreased growth rate \| delayed aggregation \| decreased cell motility \| decreased fruiting body size \| aberrant actin filament organization \| decreased chemotaxis to cAMP \| aberrant cytoskeleton organization
DBS0350990	myoA-/ myoB-/ [act15]: myoB	myoA \| myoB	delayed aggregation
DBS0350991	myoA-/ myoB-/ [act15]: myoB(1-1057)	myoA \| myoB	decreased pinocytosis \| decreased growth rate \| aberrant actin filament organization
DBS0350992	myoA-/ myoB-/ [act15]: myoB(S332)	myoA \| myoB	decreased pinocytosis \| decreased growth rate \| aberrant actin filament organization
DBS0351038	myoA-/ myoF-	myoA \| myoF	decreased lateral pseudopodium retraction \| decreased cell motility \| decreased chemotaxis to cAMP \| aberrant cell morphology \| abolished aggregation
DBS0351378	myoB-/ [act15]: GFP: myoB(1-720)	myoB	abolished protein localization to plasma membrane
DBS0351379	myoB-/ [act15]: GFP: myoB(1-800,813-1111)	myoB	abolished protein localization to actin wave \| abolished protein localization to plasma membrane
DBS0351380	myoB-/ [act15]: GFP: myoB(713-1111)	myoB	abolished protein localization to leading edge
DBS0351367	myoB-/ [act15]: myoB(S332A)	myoB	abolished protein phosphorylation
HDT6	myoB-/ myoC-	myoB \| myoC	increased secretion of lysosomal enzymes \| decreased pinocytosis \| increased filopodium formation \| decreased growth rate \| decreased cell motility \| decreased fruiting body size \| aberrant actin filament organization \| aberrant cytoskeleton organization
DBS0351031	myoD-/ myoE-	myoD \| myoE	decreased fruiting body size
DBS0351034	myoD-/ myoE-/ myoF-	myoD \| myoE \| myoF	decreased actin filament polymerization \| aberrant engulfment during phagocytosis \| decreased chemotaxis to cAMP \| decreased fruiting body size
DBS0351033	myoD-/ myoF-	myoD \| myoF	decreased fruiting body size
DBS0351032	myoE-/ myoF-	myoE \| myoF	decreased fruiting body size
DBS0351400	myoI-/ [act15]: GFP: myoI(1-1020)	myoI	abolished protein localization to pseudopodium \| decreased filopodium formation
DBS0351398	myoI-/ [act15]: GFP: myoI(2057-2357)	myoI	increased filopodium formation
DBS0351399	myoI-/ [act15]: GFP: myoI(K23333A,K2336A)	myoI	increased filopodium formation
SB14	napA-/ pirA-	napA \| pirA	decreased actin filament polymerization
DBS0350301	ncstn-/ psenA-	ncstn \| psenA	aberrant culmination \| decreased prespore cell differentiation
DBS0350125	ndufaf5--/ [act15]: ndufaf5(G86V): GFP: TAP	ndufaf5	decreased growth rate
DBS0350126	ndufaf5--/ [act15]: ndufaf5(L165F): GFP: TAP	ndufaf5	decreased growth rate
DBS0350127	ndufaf5--/ [act15]: ndufaf5(L235P): GFP: TAP	ndufaf5	decreased growth rate
DBS0350122	ndufaf5-/ [act15]: GFP: atg18	atg18 \| ndufaf5	increased number of autophagosomes
DBS0350134	ndufaf5-/ [act15]: GFP: tkt	ndufaf5 \| tkt-1 \| tkt-2	increased autophagy
DBS0304634	nfaA-/ rasG-	nfaA \| rasG	decreased establishment of cell polarity
DBS0350003	nhe1-/ [act15]: GFP: aip1	aip1 \| nhe1	decreased establishment of cell polarity \| decreased chemotaxis to cAMP
DBS0350006	nhe1-/ [act15]: GFP: aip1(E125A, E167A, F181A, F193A)	aip1 \| nhe1	abolished aggregation \| abolished chemotaxis to cAMP
DBS0350001	nhe1-/ [act15]: aip1(168-597)	aip1 \| nhe1	delayed development
DBS0350002	nhe1-/ [act15]: aip1(383-597): FLAG	aip1 \| nhe1	decreased actin filament polymerization \| abolished establishment of cell polarity \| abolished chemotaxis to cAMP
DBS0350509	nlp-/ slp-	nlp \| slp	decreased actin filament polymerization \| aberrant organelle organization \| abolished protein localization to cytoplasmic vesicle \| decreased chemotaxis to cAMP
DBS0236941	nosA-/ sonA-	nosA \| sonA	wild type
DBS0236610	noxA-/ noxB	noxA \| noxB	abolished sporulation \| aberrant sorocarp development \| decreased superoxide generation
DBS0350768	noxA-/ noxB-/ noxC-	noxA \| noxB \| noxC	aberrant defense response to bacterium
DBS0350093	nrampB-/ nramp1-	nramp1 \| nrampB	increased number of tip-organizers \| decreased defense response to Gram-negative bacterium \| delayed aggregation
DBS0306169	p2xA-/ p2xB-/ p2xC-/ p2xD-/ p2xE-	p2xA \| p2xB \| p2xC \| p2xD \| p2xE	delayed hypotonic response \| decreased growth rate
DBS0350430	pakB-/ [act15]: RFP: abpE/ [act15]: GFP: pak(1-180)	abpE-1 \| abpE-2 \| pakB	wild type
DBS0236715	pakB-/ pakC-	pakB \| pakC	decreased chemotaxis rate
DBS0350973	paxB-/ [act15]: gpaH	gpaH \| paxB	aberrant cytokinesis
DBS0304929	paxB-/ mhcA-	mhcA \| paxB	aberrant cytokinesis
DBS0235992	pdeD-/ pdeE-	pdeD \| pdeE	decreased protein localization to cell cortex \| decreased 3',5'-cyclic-GMP phosphodiesterase activity \| decreased 3',5'-cyclic-AMP phosphodiesterase activity \| decreased lateral pseudopodium formation \| increased protein kinase activation
DBS0350893	pdeD-/ pdeE-/ [unk]: pdeE	pdeD \| pdeE	delayed aggregation
DBS0350799	pdkA-/ pdkB-	pdkA \| pdkB	aberrant chemotaxis to cAMP \| development arrests at mound stage \| decreased protein kinase activation \| decreased establishment of cell polarity
DBS0350819	pdkA-/ pdkB-	pdkA \| pdkB	aberrant sorocarp development
DBS0236742	pefA-/ pefB-	pefA \| pefB	wild type
DBS0236745	pefB-/ cybA-	cybA \| pefB	wild type
DBS0236746	pefB-/ noxA-	noxA \| pefB	wild type
DBS0236747	pefB-/ noxA-/ [act15]: pefB	noxA \| pefB	aberrant sorocarp development
DBS0236748	pefB-/ noxB-	noxB \| pefB	wild type
DBS0236749	pefB-/ noxC-	noxC \| pefB	abolished sporulation \| aberrant sorocarp development
DBS0305024	pgtB-/ pgtC-	pgtB \| pgtC	aberrant cellular metabolic process \| aberrant spore coat morphology \| aberrant hyperosmotic response
DBS0304869	phg1A-/ [act15]: phg1A(1-276): phg1B221-587)	phg1A \| phg1B	decreased phagocytosis
DBS0304868	phg1A-/ [act15]: phg1B	phg1A \| phg1B	increased secretion of lysosomal enzymes \| wild type \| decreased cell-substrate adhesion \| aberrant protein level \| decreased phagocytosis
DBS0304870	phg1A-/ [act15]: phg1B(1-220): phg1a(277-642)	phg1A \| phg1B	decreased phagocytosis
DBS0304872	phg1A-/ phg1B-	phg1A \| phg1B	increased secretion of lysosomal enzymes \| decreased cell-substrate adhesion \| decreased phagocytosis \| decreased growth rate \| development arrests at tipped mound stage \| abolished culmination
DBS0302610	phgA-/ [OE]: dsgg	dsgg \| phgA	aberrant contractile vacuole organization
DBS0351455	piaA(G917D)/ [unk]: GFP: piaA(G963E)	piaA	abolished aggregation
DBS0350882	piaA(G917D)/ acrA-	acrA \| piaA	abolished gene expression \| abolished establishment of cell polarity \| abolished chemotaxis to cAMP
DBS0350877	piaA(G917D)/ hephA-	hephA \| piaA	increased response to cAMP \| wild type \| abolished activation of adenylate cyclase activity \| decreased cAMP level
DBS0236766	pikA-/ pikB-	pikA \| pikB	aberrant negative chemotaxis \| decreased response to bacterium \| decreased actin filament polymerization \| decreased activation of GTPase activity \| abolished protein localization to plasma membrane \| aberrant chemotaxis to cAMP \| decreased cell motility \| abolished protein kinase activation \| abolished protein localization to trailing edge \| decreased chemotaxis to folate \| decreased chemotaxis to cAMP \| decreased myosin II assembly
DBS0236773	pikA-/ pikB-	pikA \| pikB	abolished stream development \| decreased pinocytosis \| aberrant aggregation \| decreased exocytosis \| aberrant activation of adenylate cyclase activity \| aberrant macropinocytosis \| abolished protein localization to plasma membrane \| delayed aggregation \| decreased spore cell differentiation \| increased cAMP level \| abolished vegetative growth \| aberrant sorocarp development \| aberrant phagolysosome formation \| aberrant phagosome maturation \| decreased phosphatidylinositol biosynthesis \| aberrant fruiting body morphogenesis \| aberrant actin filament organization \| aberrant cell morphology
HM1141	pikA-/ pikB-	pikA \| pikB	decreased pinocytosis \| decreased growth rate \| decreased cell motility \| decreased taxis
DBS0350471	pikA-/ pikB-/ [act15]: GFP: cap	cap \| pikA \| pikB	wild type
DBS0252703	pikA-/ pikB-/ pikC-	pikA \| pikB \| pikC	decreased protein localization to leading edge \| increased cell motility
HM1200	pikA-/ pikB-/ pikC-/ pikF-/ pikG-	pikA \| pikB \| pikC \| pikF \| pikG	aberrant aggregation \| decreased pinocytosis \| decreased protein tyrosine phosphorylation \| increased chemotaxis to folate \| aberrant macropinocytosis \| decreased growth rate \| decreased phagocytosis \| decreased cell motility \| increased bleb assembly \| decreased chemotaxis to cAMP \| aberrant protein localization to plasma membrane \| aberrant signal transduction
HM1284	pikA-/ pikB-/ pikC-/ pikF-/ pikG-/ pikH-	pikA \| pikB \| pikC \| pikF \| pikG \| pikH	decreased defense response to Gram-negative bacterium \| decreased cell motility
HM1295	pikA-/ pikB-/ pikC-/ pikF-/ pikG-/ pten-	pikA \| pikB \| pikC \| pikF \| pikG \| pten	aberrant aggregation \| decreased defense response to Gram-negative bacterium \| decreased growth rate \| decreased cell motility \| increased resistance to N-Phenylthiourea
DBS0238073	pikA-/ pikB-/ plaA-	pikA \| pikB \| plaA	decreased actin filament polymerization \| delayed aggregation \| aberrant chemotaxis to cAMP \| abolished positive chemotaxis
DBS0350828	pinA-/ [ecmAO]: lacZ	pinA	aberrant prestalk cell differentiation
DBS0350827	pinA-/ [pspA]: lacZ	pinA	aberrant prespore cell differentiation
DBS0351206	pirA-/ pirA(K193D/ R194D): EGFP	pirA	abolished protein localization to cell periphery \| decreased protein phosphorylation
DBS0350708	pkaC-/ [act6]: pkaC(303-648)	pkaC	wild type
DBS0350707	pkaC-/ [act6]: pkaC(330-648)	pkaC	abolished aggregation
DBS0350710	pkaC-/ [dscC]: LUC	pkaC	decreased gene expression \| increased macropinocytosis
DBS0236782	pkaC-/ gdt1-	gdt1 \| pkaC	increased gene expression \| abolished aggregation
DBS0350113	pkbA-/ [act15]: GFP: rheb(Q64L)	pkbA \| rheb	decreased phagocytosis
DBS0236785	pkbA-/ pkgB-	pkbA \| pkgB	aberrant chemotaxis to cAMP \| abolished vegetative growth \| decreased chemotaxis rate \| abolished protein phosphorylation \| abolished aggregation \| aberrant cellular response to extracellular stimulus \| increased activation of GTPase activity \| increased protein kinase activation
DBS0304640	pkbA-/ pkgB-	pkbA \| pkgB	aberrant cell motility \| abolished vegetative growth
DBS0351317	pkbA-/ pkgB-	pkbA \| pkgB	aberrant macropinocytosis \| abolished vegetative growth \| abolished macropinocytosis
DBS0350919	pkcA-/ [act15]: pldB	pkcA \| pldB	aberrant aggregation \| decreased sporulation
DBS0350917	pkcA-/ [ecmA]: GFP	pkcA	aberrant prestalk gene expression
DBS0351542	pkd2-/ iplA-	iplA \| pkd2	aberrant calcium-mediated signaling
DBS0350831	plaA-/ piaA-	piaA \| plaA	decreased taxis \| decreased chemotaxis to cAMP \| aberrant actin filament organization
DBS0350486	plaA-/ sgcA-	plaA \| sgcA	aberrant chemotaxis to cAMP
DBS0350487	plaA-/ sgcA-/ pkgB-	pkgB \| plaA \| sgcA	aberrant chemotaxis to cAMP
DBS0351356	ppk1-/ [act15]: GFP: hsp48	hsp48 \| ppk1	decreased protein level
DBS0350304	psenA-/ psenB-	psenA \| psenB	increased gene expression \| abolished prespore cell differentiation \| development arrests at mound stage \| increased protein modification \| decreased phagocytosis \| aberrant calcium-mediated signaling \| increased cAMP level \| aberrant sorocarp development \| decreased macropinocytosis \| aberrant phagosome maturation \| decreased protein processing in phagocytic vesicle \| decreased prestalk gene expression \| decreased stalk cell differentiation
DBS0350305	psenA-/ psenB-/ [act15]: GFP: psenB	psenA \| psenB	wild type
DBS0350306	psenA-/ psenB-/ [act15]: psenB(D348A/ D394A)	psenA \| psenB	wild type
DBS0350298	psenB-/ psenA-	psenA \| psenB	aberrant culmination \| decreased phagocytosis \| abolished catalytic activity \| decreased prespore cell differentiation
DBS0350829	psrA-/ [unk]: FLAG: rasD(G12T)	psrA \| rasD	increased protein kinase activation
DBS0350454	pten-/ [act15]: lpten: RFP	lpten \| pten	wild type
DBS0350754	pten-/ [act15]: pten(186-515): GFP	pten	aberrant sorocarp development \| decreased chemotaxis to cAMP
DBS0350755	pten-/ [act15]: pten(C124S): GFP	pten	aberrant sorocarp development \| decreased chemotaxis to cAMP
DBS0351587	pten-/ [act15]: pten(G129E)	pten	increased lateral pseudopodium formation \| aberrant localization
DBS0349888	pten-/ gefS-	gefS \| pten	aberrant cytokinesis \| decreased chemotaxis to cAMP
DBS0349891	pten-/ pakA-	pakA \| pten	decreased chemotaxis to cAMP
DBS0349893	pten-/ pakA-/ [act15]: pakA(T585A): GFP	pakA \| pten	decreased chemotaxis to cAMP
DBS0349900	pten-/ pakA-/ [act15]: pakA(T585E): GFP	pakA \| pten	aberrant cytokinesis \| decreased chemotaxis to cAMP
DBS0349899	pten-/ pakA-/ [act15]: pakA: GFP	pakA \| pten	aberrant cytokinesis
DBS0349887	pten-/ piaA-	piaA \| pten	decreased protein kinase activity \| decreased chemotaxis to cAMP
DBS0349880	pten-/ pkbA-	pkbA \| pten	decreased chemotaxis to cAMP
DBS0349886	pten-/ pkgB-	pkgB \| pten	aberrant cytokinesis \| increased protein kinase activation
DBS0350675	ptpB-/ [act15]: 6xHis: erkA	erkA \| ptpB	aberrant stream morphology
DBS0350579	pyk3-/ phg2-	phg2 \| pyk3	abolished gene expression \| decreased protein phosphorylation \| aberrant protein localization to nucleus
DBS0351348	racE-/ [act15]: GFP: racE(G20V)	racE	decreased protein phosphorylation \| decreased chemotaxis to cAMP
DBS0351349	racE-/ [act15]: GFP: racE(G23V)	racE	increased protein phosphorylation
DBS0351350	racE-/ [act15]: GFP: racE(S192D)	racE	increased protein phosphorylation \| wild type
DBS0351347	racE-/ [act15]: GFP: racE(T25N)	racE	wild type
DBS0351614	racE-/ [act15]: GFP: racE(T25N/ S192D)	racE	wild type
DBS0351351	racE-/ [act15]: GFP: rasC(Q62L)	racE \| rasC	decreased protein phosphorylation
DBS0349949	racE-/ [act15]: fttB	fttB \| racE	decreased growth rate
DBS0349946	racE-/ [act15]: fttB: GFP	fttB \| racE	abolished protein localization to cell cortex
DBS0350956	racE-/ [act15]racE(G20V)	racE	wild type
DBS0350957	racE-/ [act15]racE(T25N)	racE	abolished cytokinesis
DBS0350631	rapgapB-/ [ecmA]: lacZ	rapgapB	aberrant cell migration to prestalk region
DBS0350632	rapgapB-/ [ecmO]: lacZ	rapgapB	aberrant cell migration to prestalk region
DBS0350740	rasC-/ [rasC]: rasG	rasC \| rasG	abolished activation of adenylate cyclase activity \| abolished aggregation
DBS0350742	rasC-/ [rasC]: rasG(1-77(D30A)): rasC(79-189)	rasC \| rasG	wild type
DBS0350741	rasC-/ [rasC]: rasG(D30A)	rasC \| rasG	aberrant aggregation \| decreased activation of adenylate cyclase activity
DBS0236855	rasC-/ dmpA-	dmpA \| rasC	abolished stream development
DBS0236857	rasC-/ rasD-	rasC \| rasD	abolished aggregation
DBS0236858	rasC-/ rasG-	rasC \| rasG	aberrant cell separation during cytokinesis \| wild type \| aberrant cell motility \| decreased activation of adenylate cyclase activity \| decreased gene expression \| abolished guanylyl cyclase activity \| abolished chemotaxis to folate \| decreased growth rate \| aberrant chemotaxis to folate \| abolished protein kinase activation \| abolished vegetative growth \| decreased cell motility \| increased protein level \| abolished aggregation \| delayed gene expression \| abolished chemotaxis to cAMP \| abolished positive regulation of chemorepellant activity
DBS0266697	rasC-/ rasG-/ [act15]: carA	carA-1 \| carA-2 \| rasC \| rasG	decreased activation of adenylate cyclase activity \| abolished activation of GTPase activity \| decreased growth rate \| abolished vegetative growth \| abolished protein kinase activation \| abolished cGMP-mediated signaling \| abolished chemotaxis to cAMP
DBS0350480	rasC-/ rasG-/ [rasG]: rasD	rasC \| rasD \| rasG	decreased chemotaxis to folate
DBS0350482	rasC-/ rasG-/ [rasG]: rasD(1-104): rasG(103-189)	rasC \| rasD \| rasG	decreased chemotaxis to folate
DBS0350481	rasC-/ rasG-/ [rasG]: rasG	rasC \| rasG	wild type
DBS0350483	rasC-/ rasG-/ [rasG]: rasG(1-104): rasD(103-187)	rasC \| rasD \| rasG	wild type
DBS0351062	rasC-/ rasG-/ [unk]: carA	carA-1 \| carA-2 \| rasC \| rasG	decreased protein localization to plasma membrane
DBS0351449	rasC-/ rasS-	rasC \| rasS	increased macropinocytosis
DBS0351213	rasC-[act15]: rasG(S17N)	rasC \| rasG	abolished activation of GTPase activity \| decreased chemotaxis to cAMP
DBS0236864	rasG-/ [OE]: rasB	rasB \| rasG	decreased growth rate
DBS0351447	rasG-/ rasS-	rasG \| rasS	decreased macropinocytosis
DBS0350688	rdeA-/ acaA-	acaA \| rdeA	increased cAMP level \| decreased sporulation
DBS0351475	regA-/ [act15]: erkA	erkA \| regA	delayed slug development
DBS0351472	regA-/ [act15]: regA(R588A,R589A,L594A,I595A,L596A)	regA	delayed development
DBS0351284	regA-/ [act15]: regA(S142A)	regA	aberrant fruiting body morphogenesis \| precocious development
DBS0351283	regA-/ [act15]: regA(S142E)	regA	delayed development
DBS0351285	regA-/ [act15]: regA(S413A)	regA	increased mound size \| delayed development
DBS0351286	regA-/ [act15]: regA(S413E)	regA	increased mound size \| delayed development
DBS0351287	regA-/ [act15]: regA(T676A)	regA	delayed sporulation
DBS0351288	regA-/ [act15]: regA(T676E)	regA	aberrant fruiting body morphogenesis \| precocious development
DBS0350670	regA-/ [regA]: regA(D212N)	regA	precocious sporulation
DBS0350380	regA-/ dhkD-	dhkD \| regA	aberrant fruiting body morphogenesis
DBS0351473	regA-/ regA(R588A,R589A,L594A,I595A,L596)	regA	precocious sporulation \| decreased mound size \| increased protein binding \| aberrant fruiting body morphogenesis
DBS0236891	regA-/ tagB-	regA \| tagB	decreased sporulation
DBS0236892	regA-/ tagC-	regA \| tagC	decreased sporulation
HM1451	rev3-/ xpf-	rev3 \| xpf	decreased resistance to cisplatin
DBS0349937	rgaA-/ ctxA-	ctxA \| rgaA	aberrant cytokinesis \| abolished protein localization to cleavage furrow
DBS0349936	rgaA-/ gapA-	gapA \| rgaA	aberrant cellular response to fluid shear stress \| aberrant cytokinesis \| abolished protein localization to cleavage furrow \| increased cell motility
DBS0350401	rgaA-/ gapA-	gapA \| rgaA	decreased protein localization to cleavage furrow \| increased myosin II assembly \| aberrant mitotic spindle organization \| increased actin filament polymerization \| decreased chemotaxis to cAMP \| increased protein kinase activation
DBS0350406	rgaA-/ gapA-/ [unk]: myc: gapA(R308E/ K317E)	gapA \| rgaA	increased protein kinase activation
DBS0350402	rgaA-/ iqgC-	iqgC \| rgaA	decreased myosin II assembly \| increased protein kinase activation
DBS0350770	ripA-/ [act15]: GFP: rapA(G12V)	rapA \| ripA	decreased protein kinase activation
DBS0350115	ripA-/ [act15]: GFP: rheb(Q64L)	rheb \| ripA	increased phagocytosis
DBS0350100	roco4-/ [unk]: roco4(1018-1292(G1179S))	roco4	increased catalytic activity
DBS0350098	roco4-/ [unk]: roco4(1018-1292(S1187A))	roco4	abolished catalytic activity
DBS0350099	roco4-/ [unk]: roco4(1018-1292(S1189A))	roco4	decreased catalytic activity
DBS0350178	rrpA-/ rrpB-/ rrpC-	rrpA \| rrpB \| rrpC	increased gene expression \| decreased gene expression
DBS0350189	rrpA-/ rrpB-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ	rrpA \| rrpB \| rrpC	abolished transitive RNA interference
DBS0350176	rrpA-/ rrpC-	rrpA \| rrpC	increased gene expression \| decreased gene expression
DBS0350187	rrpA-/ rrpC-/ [act6]: lacZ/ [AS]lacZ	rrpA \| rrpC	aberrant production of siRNA involved in RNA interference
DBS0350182	rrpA-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ	rrpA \| rrpC	abolished transitive RNA interference
DBS0350177	rrpB-/ rrpC-	rrpB \| rrpC	increased gene expression \| decreased gene expression
DBS0350185	rrpB-/ rrpC-/ [act6]: lacZ/ [AS]lacZ	rrpB \| rrpC	aberrant production of siRNA involved in RNA interference
DBS0350184	rrpB-/ rrpC-/ [act6]: lacZ/ [RNAi]lacZ	rrpB \| rrpC	abolished transitive RNA interference
DBS0350974	sadA-/ [act15]: gpaH	gpaH \| sadA	aberrant cytokinesis
DBS0349790	sadA-/ [act15]: sadA(1-923): GFP	sadA	decreased cell-substrate adhesion
DBS0349792	sadA-/ [act15]: sadA(S924A/ S925A): GFP	sadA	wild type
DBS0349791	sadA-/ [act15]: sadA(S924E/ S925E): GFP	sadA	decreased cell-substrate adhesion
DBS0351566	sbdS(1-30,TS18,31-274)/ [act15]: eIF(T56K)	eIF6 \| sbds	wild type
DBS0351524	scrA-/ [act15]: scrA(R177A,R179A,K180A,R183A,R184A,R187A,K190A,K191A,K194A)	scrA	decreased bleb assembly \| increased cellular localization \| aberrant pseudopodium formation
DBS0351611	scrA-/ [act15]: scrA(S287,290,301,335,339,384,388,389,430,432,433,437,440A)	scrA	aberrant pseudopodium formation
DBS0351522	scrA-/ [act15]: scrA(S430A,S432A,S433A,S437A,S440A)	scrA	decreased bleb assembly \| increased cellular localization \| aberrant pseudopodium formation
DBS0351523	scrA-/ [act15]: scrA(S430D,S432D,S433D,S437D,S440D)	scrA	decreased pseudopodium size
DBS0350063	scrA-/ [tet]: scrA/ mhcA-	mhcA \| scrA	aberrant cytokinesis
DBS0351610	scrA-/ [tet]: scrA/ wasA-	scrA \| wasA	aberrant cell motility \| abolished vegetative growth \| abolished bleb assembly \| aberrant pseudopodium formation
DBS0238440	scrA-/ [unk]: scrA(97-443): GFP	scrA	aberrant cytokinesis \| increased vegetative cell size \| decreased chemotaxis to cAMP \| aberrant cytoskeleton organization
SB18	scrA-/ napA-	napA \| scrA	decreased actin filament polymerization \| decreased cell motility
SB7	scrA-/ pirA-	pirA \| scrA	decreased vegetative cell size
DBS0350286	sec1-/ sec1(M250L/ A296V/ M427L/ S435R/ K505N/ V552D/ H570Q)/ gppA: GFP	gppA \| sec1	abolished contractile vacuole discharge
HM1093	sgkA-/ sgkB-	sgkA \| sgkB	decreased resistance to carboplatin \| decreased growth rate \| decreased resistance to cisplatin
DBS0266513	sigN(group1)-	sigN1 \| sigN105-1 \| sigN2 \| sigN25 \| sigN3 \| sigN4 \| sigN5	wild type
DBS0266514	sigN(group2)-	DDB_G0271820 \| sigN10 \| sigN11 \| sigN12 \| sigN14 \| sigN6 \| sigN7 \| sigN8 \| sigN9	wild type
DBS0350860	sir2D-/ [ecmAO]: lacZ	sir2D	decreased prestalk cell differentiation
DBS0350861	sir2D-/ [pspA]: lacZ	sir2D	aberrant prespore cell differentiation
DBS0302657	smlA-/ cnrN-	cnrN \| smlA	decreased fruiting body size
DBS0236940	smlA-/ ctnA-	ctnA \| smlA	increased cell-cell adhesion
DBS0304496	smlA-/ sslA1(CR11)	smlA \| sslA1	increased fruiting body size
DBS0351063	sodC-/ [unk]: rasG(C118A)	rasG \| sodC	aberrant regulation of GTPase activity
DBS0236943	spkA-1-/ spkA-2-	spkA-1 \| spkA-2	decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased mound size \| decreased chemotaxis rate \| decreased establishment of cell polarity \| aberrant cell morphology \| decreased fruiting body size
DBS0236944	spkA-1-/ spkA-2-/ [act15]: spkA: FLAG	spkA-1 \| spkA-2	aberrant aggregation \| decreased chemotaxis rate \| aberrant actin filament organization \| decreased establishment of cell polarity
DBS0350582	splB-/ pyk3-	pyk3 \| splB	abolished gene expression \| abolished protein localization to nucleus \| aberrant sorocarp development \| abolished protein phosphorylation
DBS0236948	spnA-/ arkA-	arkA \| spnA	decreased gene expression \| increased sorus size \| decreased stalk length \| delayed gene expression
DBS0350223	stlA-/ stlB-	stlA \| stlB	decreased gene expression \| increased gene expression \| aberrant gene expression \| decreased stalk width
DBS0350224	stlA-/ stlB-/ [ecmA]: lacZ	stlA \| stlB	decreased prestalk cell differentiation
DBS0350637	tagB-/ [pkaC]: pkaC	pkaC \| tagB	aberrant response to biotic stimulus \| abolished spore cell differentiation
DBS0350672	tagB-/ pkaR-	pkaR \| tagB	decreased sporulation
DBS0236974	tagB-/ psmA1-	psmA1 \| tagB	abolished sporulation
DBS0350442	talA-/ sibA-	sibA \| talA	wild type
DBS0304581	talA-/ talB-	talA \| talB	development arrests at loose mound stage \| abolished cell-substrate adhesion \| aberrant cytokinesis \| abolished cell motility \| increased bleb assembly
DBS0350713	talA-/ talB-/ [act15]: talB(K16A)	talA \| talB	decreased cell-substrate adhesion
DBS0350712	talB-/ [act15]: talB(K16A)	talB	development arrests at tipped mound stage
DBS0351501	talB-/ pikB-	pikB \| talB	aberrant cellular process
DBS0351148	tgrB1-/ tgrB1(1-827): HA	tgrB1	development arrests at mound stage
AK1540	tgrB1-/ tgrC1-	tgrB1 \| tgrC1	development arrests at loose mound stage \| abolished cell-cell self recognition \| aberrant oscillatory cAMP signaling
AK1664	tgrB1-/ tgrC1-/ alg9(-19ins)	alg9 \| tgrB1 \| tgrC1	decreased sporulation
AK1657	tgrC1-/ (QS38\|tgrC1)/ alg9(-19ins)	alg9 \| tgrC1	delayed development \| decreased fruiting body size \| decreased sporulation
JS64	tipA-/ tipB-/ [act15]: lacZ	tipA \| tipB	increased mound size \| increased number of mound tips \| development arrests at mound stage
JS98	tipA-/ tipC-/ [ecmA]: lacZ	tipA \| tipC	development arrests at loose mound stage
JS128	tipA-/ tipD-/ [ecmA]: lacZ	tipA \| tipD	development arrests at loose mound stage
JS99	tipB-/ tipC-/ [ecmA]: lacZ	tipB \| tipC	increased number of mound tips \| development arrests at tipped mound stage
JS129	tipB-/ tipD-/ [ecmA]: lacZ	tipB \| tipD	increased number of mound tips \| development arrests at tipped mound stage
DBS0350729	tipC-/ [unk]: tipC(2725-3848): GFP	tipC	decreased fruiting body size
JS130	tipC-/ tipD-/ [ecmA]: lacZ	tipC \| tipD	development arrests at loose mound stage
DBS0350507	tpp1-/ stpA-	stpA \| tpp1	wild type
DBS0351571	vacA-/ vacB-/ vacC-	vacA \| vacB \| vacC	decreased cell-substrate adhesion \| decreased gene expression \| decreased phagocytosis \| aberrant phagosome maturation \| decreased protein localization \| aberrant protein localization
DBS0351313	vasP-/ [act15]: abpB(129-295)	abpB \| vasP	aberrant cellular process
DBS0351300	vasP-/ [act15]: eYFP: vasP(S141A)	vasP	decreased protein localization to cell cortex \| wild type \| decreased lateral pseudopodium retraction \| decreased establishment of cell polarity \| aberrant actin filament organization
DBS0351301	vasP-/ [act15]: eYFP: vasP(S141D)	vasP	aberrant hyperosmotic response \| decreased filopodium formation
DBS0350466	vasP-/ [unk]: vasP(1-197: 221-380)	vasP	wild type
DBS0350467	vasP-/ [unk]: vasP(1-261: 285-380)	vasP	decreased cell motility \| abolished filopodium formation
DBS0351537	vasP-/ pirA-	pirA \| vasP	increased number of mound tips
DBS0351250	vmp1-/ [act15]: vmp1(G268L): GFP	vmp1	aberrant aggregation \| aberrant protein localization to autophagosome
DBS0237050	warA-/ hbx2-	hbx2 \| warA	increased basal disc size \| development arrests at mound stage \| decreased prespore cell differentiation \| increased prestalk O cell differentiation
DBS0351509	wasA-/ [tet]: scrA/ [unk]: GFP: wasA(I173A/ F179A)	scrA \| wasA	aberrant pseudopodium formation
DBS0351508	wasA-/ [unk]: GFP: wasA(I173A/ F179A)	wasA	aberrant protein localization to trailing edge \| decreased establishment of cell polarity
DBS0351185	washc5-/ [act15]: washc5(N457D): GFP	washc5	abolished exocytosis
DBS0350872	wshA-/ [act15]: GFP: wshA/ [act15]: vatB: RFP	vatB \| wshA	abolished endocytic recycling
DBS0350451	wshA-/ atg1-	atg1 \| wshA	wild type
DBS0350247	wshA-/ fam21-/ [act15]: GFP: wshA	fam21 \| wshA	aberrant lysosome organization
DBS0350058	yakA-/ keaA-	keaA \| yakA	wild type
DBS0351199	yakA-/ pkaC-	pkaC \| yakA	aberrant cellular response to stress
AK804	yakA-/ pufA-	pufA \| yakA	increased protein kinase activity \| increased protein level \| aberrant fruiting body morphogenesis \| increased growth rate \| precocious development

Last updated July 28, 2024


		Genomes Dictyostelium discoideum Dictyostelium purpureum Dictyostelium fasciculatum Polysphondylium pallidum Explore Learn About Dicty Teaching Protocols Dictyostelium Genome Resources D. discoideum Genome Statistics Pictures/Videos dictyArt Useful Links Virtual Library Dictyostelium Page Research Techniques Dicty Anatomy Ontology Mutant Phenotypes HTP Phenotyping at Princeton Codon Bias Table Nomenclature Guidelines Axenic Strains History Franke Dictyostelium Reference Library Tools New JBrowse Genome Browser Chromosome 1 Chromosome 2 Chromosome 3 Chromosome 4 Chromosome 5 Chromosome 6 Mitochondrial DNA Ribosomal DNA Legacy Genome Browser Chromosome 1 Chromosome 2 Chromosome 3 Chromosome 4 Chromosome 5 Chromosome 6 Mitochondrial DNA Ribosomal DNA BLAST ID Converter dictyMart Textpresso Biochemical Pathways Third Party Tools Stock Center Dicty Stock Center Home About Stock Center Search Stock Center Order Deposit Strain Catalog Plasmid Catalog Additional Materials Stock Center FAQ Nomenclature Guidelines Other Stock Centers Download Community Submit an Abstract to dictyNews Read the dictyNews ListServ Archive Add or update your colleague profile Dicty Annual Conference Job opportunities History Dicty Labs on the Web Citing dictyBase and the Dictyostelium Genome Project		About Us Contact Help